Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for neurological deficits post-meningioma surgery
NCT02084927Phase 1Unknown
- Sponsor
- Shamir Medical Center
- Start
- Apr 2014
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in cognitive impairment, sponsored by Shamir Medical Center. Primary endpoint: Neurocognitive functions at 6 months. Status: unknown.
02
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT02084927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084927.